1-20 of 26
Anna deFazio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Flurina A.M. Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer, Nicola S. Meagher, Sian Fereday, Laura Twomey, Kathleen I. Pishas, Therese Hoang, Adelyn Bolithon, Nadia Traficante, for the Australian Ovarian Cancer Study Group, Kathryn Alsop, Elizabeth L. Christie, Eun-Young Kang, Gregg S. Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J. Riggan, Jennifer Alsop, Matthias W. Beckmann, Jessica Boros, Alison H. Brand, Angela Brooks-Wilson, Michael E. Carney, Penny Coulson, Madeleine Courtney-Brooks, Kara L. Cushing-Haugen, Cezary Cybulski, Mona A. El-Bahrawy, Esther Elishaev, Ramona Erber, Simon A. Gayther, Aleksandra Gentry-Maharaj, C. Blake Gilks, Paul R. Harnett, Holly R. Harris, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y. Hernandez, Anna Jakubowska, Mercedes Jimenez-Linan, Michael E. Jones, Scott H. Kaufmann, Catherine J. Kennedy, Tomasz Kluz, Jennifer M. Koziak, Björg Kristjansdottir, Nhu D. Le, Marcin Lener, Jenny Lester, Jan Lubiński, Constantina Mateoiu, Sandra Orsulic, Matthias Ruebner, Minouk J. Schoemaker, Mitul Shah, Raghwa Sharma, Mark E. Sherman, Yurii B. Shvetsov, T. Rinda Soong, Helen Steed, Paniti Sukumvanich, Aline Talhouk, Sarah E. Taylor, Robert A. Vierkant, Chen Wang, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Michael S. Anglesio, Andrew Berchuck, James D. Brenton, Ian Campbell, Linda S. Cook, Jennifer A. Doherty, Peter A. Fasching, Renée T. Fortner, Marc T. Goodman, Jacek Gronwald, David G. Huntsman, Beth Y. Karlan, Linda E. Kelemen, Usha Menon, Francesmary Modugno, Paul D.P. Pharoah, Joellen M. Schildkraut, Karin Sundfeldt, Anthony J. Swerdlow, Ellen L. Goode, Anna DeFazio, Martin Köbel, Susan J. Ramus, David D.L. Bowtell, Dale W. Garsed
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (16): 3481–3498.
https://doi.org/10.1158/1078-0432.CCR-23-3552
Published: 15 August 2024
View article titled, Concurrent RB1 Loss and <em>BRCA</em> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Open the PDF for Concurrent RB1 Loss and <em>BRCA</em> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma in another window
Includes: Supplementary data
Journal Articles

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas

Karolin Heinze, Evan S. Cairns, Shelby Thornton, Bronwyn Harris, Katy Milne, Marcel Grube, Charlotte Meyer, Anthony N. Karnezis, Sian Fereday, Dale W. Garsed, Samuel C.Y. Leung, Derek S. Chiu, Malak Moubarak, Philipp Harter, Florian Heitz, Jessica N. McAlpine, Anna DeFazio, David D.L. Bowtell, Ellen L. Goode, Malcolm Pike, Susan J. Ramus, C. Leigh Pearce, Annette Staebler, Martin Köbel, Stefan Kommoss, Aline Talhouk, Brad H. Nelson, Michael S. Anglesio
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3471–3483.
https://doi.org/10.1158/1078-0432.CCR-22-3815
Published: 01 September 2023
View article titled, The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Open the PDF for The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas in another window
Includes: Supplementary data
Journal Articles

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S. Chiu, Michael S. Anglesio, Kylie-Ann Mallitt, Jennifer A. Doherty, Holly R. Harris, Joellen M. Schildkraut, Andrew Berchuck, Kara L. Cushing-Haugen, Ksenia Chezar, Angela Chou, Adeline Tan, Jennifer Alsop, Ellen Barlow, Matthias W. Beckmann, Jessica Boros, David D.L. Bowtell, for the AOCS Group, Alison H. Brand, James D. Brenton, Ian Campbell, Dane Cheasley, Joshua Cohen, Cezary Cybulski, Esther Elishaev, Ramona Erber, Rhonda Farrell, Anna Fischer, Zhuxuan Fu, Blake Gilks, Anthony J. Gill, for the Australian Pancreatic Genome Initiative, Charlie Gourley, Marcel Grube, Paul R. Harnett, Arndt Hartmann, Anusha Hettiaratchi, Claus K. Høgdall, Tomasz Huzarski, Anna Jakubowska, Mercedes Jimenez-Linan, Catherine J. Kennedy, Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Kim, Kayla Klett, Jennifer M. Koziak, Tiffany Lai, Angela Laslavic, Jenny Lester, Yee Leung, Na Li, Winston Liauw, Belle W.X. Lim, Anna Linder, Jan Lubiński, Sakshi Mahale, Constantina Mateoiu, Simone McInerny, Janusz Menkiszak, Parham Minoo, Suzana Mittelstadt, David Morris, Sandra Orsulic, Sang-Yoon Park, Celeste Leigh Pearce, John V. Pearson, Malcolm C. Pike, Carmel M. Quinn, Ganendra Raj Mohan, Jianyu Rao, Marjorie J. Riggan, Matthias Ruebner, Stuart Salfinger, Clare L. Scott, Mitul Shah, Helen Steed, Colin J.R. Stewart, Deepak Subramanian, Soseul Sung, Katrina Tang, Paul Timpson, Robyn L. Ward, Rebekka Wiedenhoefer, Heather Thorne, for the kConFab Investigators, Paul A. Cohen, Philip Crowe, Peter A. Fasching, Jacek Gronwald, Nicholas J. Hawkins, Estrid Høgdall, David G. Huntsman, Paul A. James, Beth Y. Karlan, Linda E. Kelemen, Stefan Kommoss, Gottfried E. Konecny, Francesmary Modugno, Sue K. Park, Annette Staebler, Karin Sundfeldt, Anna H. Wu, Aline Talhouk, Paul D.P. Pharoah, Lyndal Anderson, Anna DeFazio, Martin Köbel, Michael L. Friedlander, Susan J. Ramus
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (24): 5383–5395.
https://doi.org/10.1158/1078-0432.CCR-22-1206
Published: 15 December 2022
View article titled, Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Open the PDF for Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes in another window
Includes: Supplementary data
Journal Articles

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Kelly L. Bolton, Denise Chen, Rosario Corona de la Fuente, Zhuxuan Fu, Rajmohan Murali, Martin Köbel, Yanis Tazi, Julie M. Cunningham, Irenaeus C.C. Chan, Brian J. Wiley, Lea A. Moukarzel, Stacey J. Winham, Sebastian M. Armasu, Jenny Lester, Esther Elishaev, Angela Laslavic, Catherine J. Kennedy, Anna Piskorz, Magdalena Sekowska, Alison H. Brand, Yoke-Eng Chiew, Paul Pharoah, Kevin M. Elias, Ronny Drapkin, Michael Churchman, Charlie Gourley, Anna DeFazio, Beth Karlan, James D. Brenton, Britta Weigelt, Michael S. Anglesio, David Huntsman, Simon Gayther, Jason Konner, Francesmary Modugno, Kate Lawrenson, Ellen L. Goode, Elli Papaemmanuil
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4947–4956.
https://doi.org/10.1158/1078-0432.CCR-21-3817
Published: 14 November 2022
View article titled, Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Open the PDF for Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes in another window
Includes: Supplementary data
Journal Articles

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Aline Talhouk, Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu, Stefan Kommoss, Huei San Leong, Stephanie Chen, Maria P. Intermaggio, Blake Gilks, Tayyebeh M. Nazeran, Mila Volchek, Wafaa Elatre, Rex C. Bentley, Janine Senz, Amy Lum, Veronica Chow, Hanwei Sudderuddin, Robertson Mackenzie, Samuel C.Y. Leong, Geyi Liu, Dustin Johnson, Billy Chen, AOCS Group, Jennifer Alsop, Susana N. Banerjee, Sabine Behrens, Clara Bodelon, Alison H. Brand, Louise Brinton, Michael E. Carney, Yoke-Eng Chiew, Kara L. Cushing-Haugen, Cezary Cybulski, Darren Ennis, Sian Fereday, Renée T. Fortner, Jesús García-Donas, Aleksandra Gentry-Maharaj, Rosalind Glasspool, Teodora Goranova, Casey S. Greene, Paul Haluska, Holly R. Harris, Joy Hendley, Brenda Y. Hernandez, Esther Herpel, Mercedes Jimenez-Linan, Chloe Karpinskyj, Scott H. Kaufmann, Gary L. Keeney, Catherine J. Kennedy, Martin Köbel, Jennifer M. Koziak, Melissa C. Larson, Jenny Lester, Liz-Anne Lewsley, Jolanta Lissowska, Jan Lubiński, Hugh Luk, Geoff Macintyre, Sven Mahner, Iain A. McNeish, Janusz Menkiszak, Nikilyn Nevins, Ana Osorio, Oleg Oszurek, José Palacios, Samantha Hinsley, Celeste L. Pearce, Malcolm C. Pike, Anna M. Piskorz, Isabelle Ray-Coquard, Valerie Rhenius, Cristina Rodriguez-Antona, Raghwa Sharma, Mark E. Sherman, Dilrini De Silva, Naveena Singh, Peter Sinn, Dennis Slamon, Honglin Song, Helen Steed, Euan A. Stronach, Pamela J. Thompson, Aleksandra Tołoczko, Britton Trabert, Nadia Traficante, Chiu-Chen Tseng, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Boris Winterhoff, Alicia Beeghly-Fadiel, Javier Benitez, Andrew Berchuck, James D. Brenton, Robert Brown, Jenny Chang-Claude, Georgia Chenevix-Trench, Anna deFazio, Peter A. Fasching, María J. García, Simon A. Gayther, Marc T. Goodman, Jacek Gronwald, Michelle J. Henderson, Beth Y. Karlan, Linda E. Kelemen, Usha Menon, Sandra Orsulic, Paul D.P. Pharoah, Nicolas Wentzensen, Anna H. Wu, Joellen M. Schildkraut, Mary Anne Rossing, Gottfried E. Konecny, David G. Huntsman, Ruby Yun-Ju Huang, Ellen L. Goode, Susan J. Ramus, Jennifer A. Doherty, David D. Bowtell, Michael S. Anglesio
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5411–5423.
https://doi.org/10.1158/1078-0432.CCR-20-0103
Published: 15 October 2020
View article titled, Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Open the PDF for Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE) in another window
Includes: Supplementary data
Journal Articles

Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance

Dongli Liu, Miya John, Claire E. Henry, Elizabeth L. Christie, David D.L. Bowtell, Kristina Tang, Viola Heinzelmann-Schwarz, Catherine Kennedy, Jessica Boros, Anna DeFazio, Caroline E. Ford
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A41.
https://doi.org/10.1158/1557-3265.OVCA19-A41
Published: 01 July 2020
View article titled, Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance
Journal Articles

Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer

Dale Garsed, Ahwan Pandey, Sian Fereday, Kathryn Alsop, Maartje Wouters, Flurina Saner, Catherine Kennedy, Celeste Pearce, Malcolm Pike, Susan Ramus, Martin Kobel, Anna deFazio, Ellen Goode, Brad Nelson, David Bowtell
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): IA05.
https://doi.org/10.1158/1557-3265.OVCA19-IA05
Published: 01 July 2020
View article titled, Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer
Journal Articles

Abstract B37: Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer

Marina Pavanello, Ed Dicks, Honglin Song, Amir Ariff, Adelyn Bolithon, Maria P. Intermaggio, Mark Pinese, Kirsten Moysich, Kunle O. Odunsi, Ellen Goode, David D. Bowtell, Peter Fasching, Jennifer A. Doherty, Francesmary Modugno, Susanne K. Kjær, Penelope M. Webb, Anna Wu, Anna deFazio, Ovarian Cancer Association Consortium, Paul James, Deepak Subramanian, Ian Campbell, Simon A. Gayther, Paul D.P. Pharoah, Susan J. Ramus
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): B37.
https://doi.org/10.1158/1557-3265.OVCA19-B37
Published: 01 July 2020
View article titled, Abstract B37: Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer
Journal Articles

Abstract A48: Antiapoptotic gene expression and sensitivity to BH3-mimetics in chemoresistant, high-grade serous ovarian cancer cell lines

Cristina Mapagu, Sivatharsny Srirangan, George Au-Yeung, Australian Ovarian Cancer Study, Paul R. Harnett, David D. Bowtell, Anna deFazio
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A48.
https://doi.org/10.1158/1557-3265.OVCA19-A48
Published: 01 July 2020
View article titled, Abstract A48: Antiapoptotic gene expression and sensitivity to BH3-mimetics in chemoresistant, high-grade serous ovarian cancer cell lines
Journal Articles

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer

Dale W. Garsed, Kathryn Alsop, Sian Fereday, Catherine Emmanuel, Catherine J. Kennedy, Dariush Etemadmoghadam, Bo Gao, Val Gebski, Valérie Garès, Elizabeth L. Christie, Maartje C.A. Wouters, Katy Milne, Joshy George, Ann-Marie Patch, Jason Li, Gisela Mir Arnau, Timothy Semple, Sreeja R. Gadipally, Yoke-Eng Chiew, Joy Hendley, Thomas Mikeska, Giada V. Zapparoli, Kaushalya Amarasinghe, Sean M. Grimmond, John V. Pearson, Nicola Waddell, Jillian Hung, Colin J.R. Stewart, Raghwa Sharma, Prue E. Allan, Peter F. Rambau, Orla McNally, Linda Mileshkin, Anne Hamilton, Sumitra Ananda, Marisa Grossi, Paul A. Cohen, Yee C. Leung, Robert M. Rome, Philip Beale, Penny Blomfield, Michael Friedlander, Alison Brand, Alexander Dobrovic, Martin Köbel, Paul Harnett, Brad H. Nelson, David D. L. Bowtell, Anna deFazio, Nadia Traficante, for the Australian Ovarian Cancer Study Group
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (3): 569–580.
https://doi.org/10.1158/1078-0432.CCR-17-1621
Published: 31 January 2018
View article titled, Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
Open the PDF for Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A25: BRAFV600E mutations in serous ovarian cancer and response to the BRAF inhibitor, dabrafenib.

Anna DeFazio, Tania Moujaber, Dariush Etemadmoghadam, Catherine Kennedy, Yoke-Eng Chiew, Rosemary L. Balleine, Catherine Saunders, Gerard V. Wain, Alexander Dobrovic, Australian Ovarian Cancer Study Group (AOCS), David DL Bowtell, Paul R. Harnett
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A25.
https://doi.org/10.1158/1557-3265.OVCA15-A25
Published: 15 January 2016
View article titled, Abstract A25: BRAFV600E mutations in serous ovarian cancer and response to the BRAF inhibitor, dabrafenib.
Journal Articles

Abstract B08: Genomics analyses of less common epithelial ovarian cancer subtypes.

Kylie L. Gorringe, Matthew Wakefield, Sally M. Hunter, Georgina L. Ryland, Dane Cheasley, Michael S. Anglesio, Michael Christie, Raghwa Sharma, Antill Yoland, Simone M. Rowley, Jason Li, Blake Gilks, Prue E. Allan, Andrew N. Stephens, Sumi Ananda, Jan Pyman, Martin Koebel, Jessica McAlpine, Charlie Gourley, David G. Huntsman, Anna deFazio, David DL Bowtell, Ian G. Campbell, Clare Scott
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): B08.
https://doi.org/10.1158/1557-3265.OVCA15-B08
Published: 15 January 2016
View article titled, Abstract B08: Genomics analyses of less common epithelial ovarian cancer subtypes.
Journal Articles

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

Sharon E. Johnatty, Jonathan P. Tyrer, Siddhartha Kar, Jonathan Beesley, Yi Lu, Bo Gao, Peter A. Fasching, Alexander Hein, Arif B. Ekici, Matthias W. Beckmann, Diether Lambrechts, Els Van Nieuwenhuysen, Ignace Vergote, Sandrina Lambrechts, Mary Anne Rossing, Jennifer A. Doherty, Jenny Chang-Claude, Francesmary Modugno, Roberta B. Ness, Kirsten B. Moysich, Douglas A. Levine, Lambertus A. Kiemeney, Leon F.A.G. Massuger, Jacek Gronwald, Jan Lubiński, Anna Jakubowska, Cezary Cybulski, Louise Brinton, Jolanta Lissowska, Nicolas Wentzensen, Honglin Song, Valerie Rhenius, Ian Campbell, Diana Eccles, Weiva Sieh, Alice S. Whittemore, Valerie McGuire, Joseph H. Rothstein, Rebecca Sutphen, Hoda Anton-Culver, Argyrios Ziogas, Simon A. Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J. Ramus, Celeste L. Pearce, Malcolm C. Pike, Daniel O. Stram, Anna H. Wu, Jolanta Kupryjanczyk, Agnieszka Dansonka-Mieszkowska, Iwona K. Rzepecka, Beata Spiewankiewicz, Marc T. Goodman, Lynne R. Wilkens, Michael E. Carney, Pamela J. Thompson, Florian Heitz, Andreas du Bois, Ira Schwaab, Philipp Harter, Jacobus Pisterer, Peter Hillemanns, on behalf of the AGO Study Group, Beth Y. Karlan, Christine Walsh, Jenny Lester, Sandra Orsulic, Stacey J. Winham, Madalene Earp, Melissa C. Larson, Zachary C. Fogarty, Estrid Høgdall, Allan Jensen, Susanne Kruger Kjaer, Brooke L. Fridley, Julie M. Cunningham, Robert A. Vierkant, Joellen M. Schildkraut, Edwin S. Iversen, Kathryn L. Terry, Daniel W. Cramer, Elisa V. Bandera, Irene Orlow, Tanja Pejovic, Yukie Bean, Claus Høgdall, Lene Lundvall, Ian McNeish, James Paul, Karen Carty, Nadeem Siddiqui, Rosalind Glasspool, Thomas Sellers, Catherine Kennedy, Yoke-Eng Chiew, Andrew Berchuck, Stuart MacGregor, Paul D.P. Pharoah, Ellen L. Goode, Anna deFazio, Penelope M. Webb, Georgia Chenevix-Trench
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (23): 5264–5276.
https://doi.org/10.1158/1078-0432.CCR-15-0632
Published: 30 November 2015
View article titled, Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Open the PDF for Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium in another window
Includes: Supplementary data
Journal Articles

Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver

Catherine Emmanuel, Yoke-Eng Chiew, Joshy George, Dariush Etemadmoghadam, Michael S. Anglesio, Raghwa Sharma, Peter Russell, Catherine Kennedy, Sian Fereday, Jillian Hung, Laura Galletta, Russell Hogg, Gerard V. Wain, Alison Brand, Rosemary Balleine, Laura MacConaill, Emanuele Palescandolo, Sally M. Hunter, Ian Campbell, Alexander Dobrovic, Stephen Q. Wong, Hongdo Do, Christine L. Clarke, Paul R. Harnett, David D.L. Bowtell, Anna deFazio
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6618–6630.
https://doi.org/10.1158/1078-0432.CCR-14-1292
Published: 14 December 2014
View article titled, Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <em>TP53</em>-Mutant Tumors and Identifies <em>NRAS</em> as an Oncogenic Driver
Open the PDF for Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <em>TP53</em>-Mutant Tumors and Identifies <em>NRAS</em> as an Oncogenic Driver in another window
Includes: Supplementary data
Journal Articles

Abstract A13: Molecular profiling of low grade serous ovarian tumors

Sally M. Hunter, Kylie L. Gorringe, Michael S. Anglesio, Raghwa Sharma, Yoke-Eng Chiew, Phillip Moss, Andrew Stephens, C Blake Gilks, Group Australian Ovarian Cancer Study, David Hunstman, Anna deFazio, Ian Campbell
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A13.
https://doi.org/10.1158/1078-0432.OVCA13-A13
Published: 13 May 2014
View article titled, Abstract A13: Molecular profiling of low grade serous ovarian tumors
Journal Articles

Abstract A29: Loss of histone H2B monoubiquitination in ovarian cancer – new therapeutic targeting opportunities based on chromatin relaxation

Deborah J. Marsh, Anna deFazio, Adele Clarkson, Catherine Kennedy, Gregory G. Gard, Anthony J. Gill
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A29.
https://doi.org/10.1158/1078-0432.OVCA13-A29
Published: 13 May 2014
View article titled, Abstract A29: Loss of histone H2B monoubiquitination in ovarian cancer – new therapeutic targeting opportunities based on chromatin relaxation
Journal Articles

Abstract A3: Mucinous ovarian tumors: Are they all the same?

Ian Campbell, Sally Hunter, Wakefield Mathew, Yoland Antill, Susie Bae, Sumitra Ananda, Monique Topp, Lara Lipton, Winston Liauw, Thomas Jobling, Alex Boussioutas, Michael Christie, Prue Allan, Michael Friedlander, Stephen Fox, Anna Defazio, David Bowtell, Jan Pyman, Study Australian Ovarian Cancer, Clare Scott, Kylie Gorringe
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A3.
https://doi.org/10.1158/1078-0432.OVCA13-A3
Published: 13 May 2014
View article titled, Abstract A3: Mucinous ovarian tumors: Are they all the same?
Journal Articles

Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations

Joshy George, Kathryn Alsop, Dariush Etemadmoghadam, Heather Hondow, Thomas Mikeska, Alexander Dobrovic, Anna deFazio, for the Australian Ovarian Cancer Study Group, Gordon K. Smyth, Douglas A. Levine, Gillian Mitchell, David D. Bowtell
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (13): 3474–3484.
https://doi.org/10.1158/1078-0432.CCR-13-0066
Published: 30 June 2013
View article titled, Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <em>BRCA1</em> and <em>BRCA2</em> Mutations
Open the PDF for Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <em>BRCA1</em> and <em>BRCA2</em> Mutations in another window
Includes: Supplementary data
Journal Articles

Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Zhigang C. Wang, Nicolai Juul Birkbak, Aedín C. Culhane, Ronny Drapkin, Aquila Fatima, Ruiyang Tian, Matthew Schwede, Kathryn Alsop, Kathryn E. Daniels, Huiying Piao, Joyce Liu, Dariush Etemadmoghadam, Alexander Miron, Helga B. Salvesen, Gillian Mitchell, Anna DeFazio, John Quackenbush, Ross S. Berkowitz, J. Dirk Iglehart, David D.L. Bowtell, for the Australian Ovarian Cancer Study Group, Ursula A. Matulonis
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5806–5815.
https://doi.org/10.1158/1078-0432.CCR-12-0857
Published: 14 October 2012
View article titled, Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
Open the PDF for Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome in another window
Includes: Supplementary data
Journal Articles

Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?

Sally M. Hunter, Michael S. Anglesio, Raghwa Sharma, C. Blake Gilks, Nataliya Melnyk, Yoke-Eng Chiew, Anna deFazio, Teri A. Longacre, David G. Huntsman, Kylie L. Gorringe, Ian G. Campbell
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7273–7282.
https://doi.org/10.1158/1078-0432.CCR-11-2080
Published: 30 November 2011
View article titled, Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?
Open the PDF for Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification? in another window
Includes: Supplementary data